Reoperation rates of anterior cervical discectomy and fusion versus posterior laminoplasty for multilevel cervical degenerative diseases: a population-based cohort study in Taiwan

医学 颈椎前路椎间盘切除融合术 外科 椎板成形术 危险系数 置信区间 背景(考古学) 人口 回顾性队列研究 退行性椎间盘病 队列 脊髓病 内科学 腰椎 颈椎 脊髓 古生物学 精神科 环境卫生 生物
作者
Ji-Ping Lin,Li‐Nien Chien,Wan Ling Tsai,Li Ying Chen,Yi Chen Hsieh,Yung Hsiao Chiang
出处
期刊:The Spine Journal [Elsevier BV]
卷期号:16 (12): 1428-1436 被引量:10
标识
DOI:10.1016/j.spinee.2016.08.017
摘要

Background Context The reoperation (reop) rate is a crucial indicator of the efficacy of an operation; however, studies on the reop rates of anterior cervical discectomy and fusion (ACDF) or posterior laminoplasty (LMP) for treating multilevel cervical degenerative diseases (MCDDs) are scant. Purpose This study aimed to compare the reop rates and safety of ACDF and LMP for MCDD treatment. Study Design This is a retrospective population-based cohort study. Patient Sample Our sample consists of patients who underwent ACDF and LMP treatment. Outcome Measures Reop rate, risk of pneumonia, sepsis, surgery-related complications, and death. Methods A total of 6,605 patients who underwent ACDF and 1,578 patients who underwent LMP for MCDD treatment from 2001 to 2011 were selected from the Taiwan National Health Insurance Research Database. Cox proportional hazard models were performed to compare the clinical outcomes of the patients who underwent ACDF with those of the patients who underwent LMP. Results Long-term reop rates (per 100 person-month) were slightly Anterior cervical discectomy and fusion; in the patients who underwent ACDF (0.04 [95% confidence interval, CI: 0.03–0.05]) than in those who underwent LMP (0.06 [95% CI: 0.04–0.08]), with adjusted hazard ratio (HR) of 1.43 (95% CI: 0.96–2.11, p=.08), although short-term reop rates were significantly higher in the LMP group (0.41 [95% CI: 0.33–0.51]) than in the ACDF group (0.09 [95% CI: 0.07–0.11]), with adjusted HR of 4.81 (95% CI: 3.46–6.69, p<.001). Patients who underwent LMP had a lower risk of pneumonia, sepsis, surgery-related complications, and death than did those who underwent ACDF within a year of follow-up. The results after adjustment for all covariates showed that osteoarthritis (adjusted HR=2.07, 95% CI: 1.40–3.06, p<.01) was associated with reop risk in the patients who underwent ACDF, and diabetes (adjusted HR=3.27, 95% CI: 1.12–9.54, p=.03) was associated with reop risk in the patients who underwent LMP. Conclusions There was no significantly higher incidence rate of reop between the patients who underwent LMP and those who underwent ACDF after 1-year follow-up; however, ACDF was associated with a higher rate of 1-year complications and mortality compared with LMP. LMP might be considered as a treatment option for MCDD but could not be appropriate for patients with cervical kyphotic deformity.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
mumeinv完成签到,获得积分20
刚刚
刚刚
HDrinnk发布了新的文献求助10
刚刚
3秒前
3秒前
4秒前
4秒前
英俊的铭应助科研通管家采纳,获得10
4秒前
Orange应助科研通管家采纳,获得10
5秒前
5秒前
丘比特应助科研通管家采纳,获得10
5秒前
天天快乐应助科研通管家采纳,获得10
5秒前
深情安青应助科研通管家采纳,获得10
5秒前
小新应助科研通管家采纳,获得10
5秒前
科研通AI6.3应助mumeinv采纳,获得10
5秒前
vc应助科研通管家采纳,获得10
5秒前
5秒前
5秒前
充电宝应助科研通管家采纳,获得10
5秒前
5秒前
上官若男应助科研通管家采纳,获得10
5秒前
5秒前
FashionBoy应助科研通管家采纳,获得10
5秒前
5秒前
5秒前
领导范儿应助科研通管家采纳,获得10
5秒前
5秒前
6秒前
6秒前
脑洞疼应助科研通管家采纳,获得10
6秒前
6秒前
7秒前
原野发布了新的文献求助10
8秒前
既白发布了新的文献求助10
9秒前
啦啦啦发布了新的文献求助10
10秒前
11秒前
太阳发布了新的文献求助10
11秒前
11秒前
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
晶种分解过程与铝酸钠溶液混合强度关系的探讨 8888
Les Mantodea de Guyane Insecta, Polyneoptera 2000
Leading Academic-Practice Partnerships in Nursing and Healthcare: A Paradigm for Change 800
Signals, Systems, and Signal Processing 610
The Sage Handbook of Digital Labour 600
The formation of Australian attitudes towards China, 1918-1941 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6416831
求助须知:如何正确求助?哪些是违规求助? 8235933
关于积分的说明 17493857
捐赠科研通 5469671
什么是DOI,文献DOI怎么找? 2889606
邀请新用户注册赠送积分活动 1866601
关于科研通互助平台的介绍 1703748